Biogen Inc. (BIIB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biogen Inc.

    NASDAQ: BIIB · Real-Time Price · USD
    141.35
    0.68 (0.48%)
    At close: Sep 08, 2025, 3:59 PM
    140.02
    -0.94%
    After-hours: Sep 08, 2025, 05:55 PM EDT

    Biogen Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.68B 9.84B 10.17B 10.98B
    Cost of Revenue
    		 2.31B 2.53B 2.28B 2.11B
    Gross Profit
    		 7.37B 7.3B 7.9B 8.87B
    Operating Income
    		 2.22B 2.1B 2.9B 2.84B
    Interest Income
    		 67.6M 276.5M 89.3M 11M
    Pretax Income
    		 1.91B 1.3B 3.59B 1.75B
    Net Income
    		 1.63B 1.16B 3.05B 1.56B
    Selling & General & Admin
    		 2.4B 2.5B 2.4B 2.67B
    Research & Development
    		 2.04B 2.46B 2.23B 2.5B
    Other Expenses
    		 701.1M 993.7M 358.5M 888.5M
    Operating Expenses
    		 5.15B 5.2B 4.99B 6.06B
    Interest Expense
    		 250.3M 246.9M 246.6M 253.6M
    Selling & Marketing Expenses
    		 n/a 71.4M 54.1M 98.7M
    Cost & Expenses
    		 7.46B 8B 7.27B 8.17B
    Income Tax Expense
    		 273.8M 135.3M 632.8M 52.5M
    Shares Outstanding (Basic)
    		 145.7M 144.7M 145.3M 149.1M
    Shares Outstanding (Diluted)
    		 145.9M 145.6M 146M 149.6M
    EPS (Basic)
    		 11.20 8.02 20.97 10.44
    EPS (Diluted)
    		 11.19 7.97 20.87 10.40
    EBITDA
    		 2.83B 2.38B 4.36B 3.92B
    EBIT
    		 2.16B 1.88B 3.84B 2B
    Depreciation & Amortization
    		 673.2M 494.8M 518.7M 487.3M

    Add to Watchlist